News Agency
Men's Weekly

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

  • Written by PR Newswire

Initiation of Phase 2 Clinical Trial Expected in CY Q1 2022

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

MELBOURNE, Australia, Dec. 14, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that the New Zealand...

Read more: Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2...

The Role of Stainless Steel Suppliers in Australia’s Industry

Stainless steel has become a cornerstone of modern industry, valued for its strength, durability, and resistance to corrosion. From construction and manufacturing to kitchenware and medical equipment, stainless steel plays a vital role in countless applications. Central to this supply... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion